End-Of-Life Decision Making and Preparedness Planning Among Heart Failure Patients Hospitalized for Advanced Disease

Sponsor
Saint Luke's Health System (Other)
Overall Status
Withdrawn
CT.gov ID
NCT02398617
Collaborator
(none)
0
1
1
12
0

Study Details

Study Description

Brief Summary

Heart failure is a chronic and frequently terminal illness associated with poor quality of life and high burden of morbidity, re-hospitalization, and cost. Accordingly, recent guideline updates have highlighted the need for improved focus on end-of-life and palliative care of advanced heart failure patients, in whom symptom burden can be high and treatment options are often limited. The aims of this study are to evaluate the feasibility of implementing a semi-structured, outpatient, nurse practitioner-led, educational supportive care intervention concerning multiple domains of end-of-life care not often included in regular, outpatient clinic visits.

Condition or Disease Intervention/Treatment Phase
  • Other: Decision Making Intervention
N/A

Detailed Description

This study will be a prospective pilot enrolling 10 patients with advanced disease admitted to the heart failure service at St. Luke's Mid America Heart Institute and who are not candidates for advanced therapies such as heart transplant or mechanical circulatory support (left ventricular assist device). Potential enrollees will be identified using a validated risk model that predicts death or poor quality of life in the six months after discharge from the hospital for heart failure exacerbation. Enrolled patients will complete validated questionnaires while still hospitalized, regarding health-related quality of life, illness acceptance, prioritization of different life goals, and confidence in decision-making regarding their terminal heart failure. Patients will then be given a paper exercise regarding delineation of an end-of-life plan and appointment of a surrogate medical decision-maker, to be completed after discharge. At their regularly scheduled admission follow-up visit with seven days of discharge, participants will be asked to bring their medical decision maker and participate in a semi-structured supplemental palliative care/education session facilitated by a heart failure nurse practitioner trained in palliative care discussions. Domains included in the intervention will include disease literacy and understanding, goals of care, legal issues for patients with terminal illness, symptom management, health-related quality of life, caregiver burden, patient autonomy, healthcare utilization, and establishment of end-of-life plans.

Outcomes to be measured after the intervention include repeated validated questionnaires and unstructured patient interviews at 1 month and, at 6 months, creation of a formalized end-of-life plan, change in code status, obtainment of an advanced directive, designation of a durable power of attorney, frequency of re-hospitalizations, emergency room visits and unscheduled clinic visits with providers, and death. These will be obtained at the time of regularly scheduled heart failure clinic follow-up visits or over the phone.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Facilitating End-Of-Life Decision Making and Preparedness Planning Among Heart Failure Patients Hospitalized for Advanced Disease
Study Start Date :
Dec 1, 2014
Actual Primary Completion Date :
Jun 1, 2015
Anticipated Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Other: Decision Making Intervention

At their regularly scheduled admission follow-up visit with seven days of discharge, participants will be asked to bring their medical decision maker and participate in a semi-structured supplemental palliative care/education session facilitated by a heart failure nurse practitioner trained in palliative care discussions. Domains included in the intervention will include disease literacy and understanding, goals of care, legal issues for patients with terminal illness, symptom management, health-related quality of life, caregiver burden, patient autonomy, healthcare utilization, and establishment of end-of-life plans.

Other: Decision Making Intervention
At their regularly scheduled admission follow-up visit with seven days of discharge, participants will be asked to bring their medical decision maker and participate in a semi-structured supplemental palliative care/education session facilitated by a heart failure nurse practitioner trained in palliative care discussions. Domains included in the intervention will include disease literacy and understanding, goals of care, legal issues for patients with terminal illness, symptom management, health-related quality of life, caregiver burden, patient autonomy, healthcare utilization, and establishment of end-of-life plans.

Outcome Measures

Primary Outcome Measures

  1. Kansas City Cardiomyopathy Questionnaire (KCCQ) [1 month]

    Heart failure-related quality of life

  2. Decisional Conflict Scale [1 month]

    Decision-making confidence/readiness

  3. Peace, Equanimity, and Acceptance in Cancer Experience (PEACE) Scale [1 month]

    Illness Acceptance

  4. Kaldjian's Goals of Care at End of Life [1 month]

    Patient-ranked importance for different goals of care

Secondary Outcome Measures

  1. Death [6 months]

    Mortality

  2. Code Status Change [6 months]

  3. Advance Directive creation [6 months]

  4. Durable Power of Attorney appointment [6 months]

  5. Unscheduled Healthcare Encounter [6 months]

    Composite of re-hospitalizations, emergency department visits, urgent care visits, and unscheduled outpatient heart failure clinic visits

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • advanced heart failure

  • ineligible for advanced therapies

  • 50% risk of death or continued poor heart failure-related health status at 6 months from hospital discharge, based on validated risk score

Exclusion Criteria:
  • Hospice enrollment

  • Previous heart transplant or left ventricular assist device placement

Contacts and Locations

Locations

Site City State Country Postal Code
1 Saint Luke's Hospital Kansas City Missouri United States 64111

Sponsors and Collaborators

  • Saint Luke's Health System

Investigators

  • Principal Investigator: John A Spertus, MD, MPH, Saint Luke's Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Saint Luke's Health System
ClinicalTrials.gov Identifier:
NCT02398617
Other Study ID Numbers:
  • 14-192
First Posted:
Mar 25, 2015
Last Update Posted:
Oct 19, 2021
Last Verified:
Oct 1, 2021
Keywords provided by Saint Luke's Health System
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 19, 2021